Oncology & Cancer

Researchers discover new molecular driver of retinoblastoma

Despite decades of medical advances, children who develop the pediatric eye cancer retinoblastoma often lose their vision or an eye due to a lack of specific, targeted therapies and a poor molecular understanding of the cancer. ...

Oncology & Cancer

What do you know about these three rare childhood cancers?

Childhood cancer rates have been rising slightly for the past few decades, and about 10,470 children in the U.S. under the age of 15 will be diagnosed with cancer in 2022, according to the American Cancer Society.

Oncology & Cancer

Researchers help make pediatric eye cancer easier to detect

Can parents use digital cameras and smart phones to potentially screen their children for the most common form of pediatric eye cancer? Baylor University and Harvard Medical School researchers believe so.

Oncology & Cancer

US-born Latinas at great risk of having babies with retinoblastoma

In a large epidemiologic study, researchers at UCLA's Jonsson Cancer Center found that the children of U.S.-born Latina women are at higher risk of having retinoblastoma, a malignant tumor of the retina which typically occurs ...

Oncology & Cancer

Ototoxicity rates in children receiving carboplatin studied

(HealthDay) -- Retinoblastoma patients who are younger than 6 months of age at the start of carboplatin treatment experience a higher incidence of ototoxicity, according to a study published online Feb. 27 in the Journal ...

Oncology & Cancer

Expert reviews the current state of retinoblastoma research

Retinoblastoma is a rare pediatric cancer, with approximately 250–300 new cases per year in the United States and 8,000 worldwide. The cancer grows within the retina, a thin layer of cells at the back of the eye, and is ...

page 2 from 3